Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 5 | 2016 | 706 | 0.610 |
Why?
|
| Exosomes | 2 | 2016 | 101 | 0.590 |
Why?
|
| Arteries | 1 | 2017 | 65 | 0.560 |
Why?
|
| Macrophages | 1 | 2015 | 439 | 0.410 |
Why?
|
| Aging | 1 | 2017 | 664 | 0.410 |
Why?
|
| MicroRNAs | 1 | 2015 | 426 | 0.360 |
Why?
|
| Brain | 1 | 2017 | 1346 | 0.330 |
Why?
|
| HIV Infections | 4 | 2016 | 2303 | 0.320 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2013 | 51 | 0.300 |
Why?
|
| Autopsy | 1 | 2017 | 43 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 306 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2379 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 215 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 513 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2013 | 308 | 0.110 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 50 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1502 | 0.100 |
Why?
|
| Transport Vesicles | 1 | 2010 | 21 | 0.090 |
Why?
|
| Humans | 8 | 2022 | 37093 | 0.090 |
Why?
|
| Young Adult | 2 | 2017 | 4268 | 0.090 |
Why?
|
| Aged | 3 | 2017 | 6741 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2012 | 808 | 0.080 |
Why?
|
| Middle Aged | 3 | 2017 | 10129 | 0.070 |
Why?
|
| Adult | 3 | 2017 | 11712 | 0.060 |
Why?
|
| Female | 4 | 2022 | 20969 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 50 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2003 | 63 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 37 | 0.050 |
Why?
|
| Male | 3 | 2017 | 20025 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 1180 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 1568 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2012 | 51 | 0.050 |
Why?
|
| Transfection | 2 | 2013 | 523 | 0.050 |
Why?
|
| Peptides | 1 | 2022 | 320 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 571 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1198 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2231 | 0.030 |
Why?
|
| Virion | 1 | 2016 | 69 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 121 | 0.030 |
Why?
|
| China | 1 | 2015 | 196 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 448 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 91 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 47 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 173 | 0.030 |
Why?
|
| Static Electricity | 1 | 2012 | 78 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 409 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 183 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1518 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2012 | 265 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 145 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 216 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1455 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 408 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 133 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 26 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 972 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 295 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 302 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 935 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1354 | 0.020 |
Why?
|
| United States | 1 | 2015 | 4223 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1095 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 5363 | 0.020 |
Why?
|
| Barbados | 1 | 2003 | 3 | 0.010 |
Why?
|
| HIV Protease | 1 | 2003 | 21 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2003 | 33 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2003 | 55 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 474 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 387 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 644 | 0.010 |
Why?
|